Geode Capital Management’s Biolase, Inc. BIOL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-549
| Closed | -$3.88K | – | 4804 |
|
|
2023
Q2 | $3.88K | Hold |
549
| – | – | ﹤0.01% | 4745 |
|
|
2023
Q1 | $15.4K | Hold |
549
| – | – | ﹤0.01% | 4730 |
|
|
2022
Q4 | $35K | Hold |
549
| – | – | ﹤0.01% | 4686 |
|
|
2022
Q3 | $133K | Hold |
549
| – | – | ﹤0.01% | 4421 |
|
|
2022
Q2 | $251K | Buy |
549
+20
| +4% | +$11K | ﹤0.01% | 4133 |
|
|
2022
Q1 | $467K | Hold |
529
| – | – | ﹤0.01% | 3966 |
|
|
2021
Q4 | $516K | Hold |
529
| – | – | ﹤0.01% | 4028 |
|
|
2021
Q3 | $846K | Buy |
529
+45
| +9% | +$73.5K | ﹤0.01% | 3770 |
|
|
2021
Q2 | $844K | Buy |
484
+7
| +1% | +$13K | ﹤0.01% | 3691 |
|
|
2021
Q1 | $1M | Buy |
477
+276
| +137% | +$678K | ﹤0.01% | 3563 |
|
|
2020
Q4 | $209K | Buy |
201
+182
| +958% | +$139K | ﹤0.01% | 3869 |
|
|
2020
Q3 | $13K | Hold |
19
| – | – | ﹤0.01% | 4139 |
|
|
2020
Q2 | $22K | Hold |
19
| – | – | ﹤0.01% | 4064 |
|
|
2020
Q1 | $18K | Hold |
19
| – | – | ﹤0.01% | 4044 |
|
|
2019
Q4 | $26K | Hold |
19
| – | – | ﹤0.01% | 4135 |
|
|
2019
Q3 | $46K | Hold |
19
| – | – | ﹤0.01% | 4073 |
|
|
2019
Q2 | $68K | Hold |
19
| – | – | ﹤0.01% | 4030 |
|
|
2019
Q1 | $110K | Buy |
19
+1
| +6% | +$4.86K | ﹤0.01% | 3879 |
|
|
2018
Q4 | $44K | Hold |
18
| – | – | ﹤0.01% | 4014 |
|
|
2018
Q3 | $93K | Buy |
18
+2
| +13% | +$8K | ﹤0.01% | 3947 |
|
|
2018
Q2 | $49K | Hold |
16
| – | – | ﹤0.01% | 3980 |
|
|
2018
Q1 | $84K | Hold |
16
| – | – | ﹤0.01% | 3875 |
|
|
2017
Q4 | $87K | Hold |
16
| – | – | ﹤0.01% | 3847 |
|
|
2017
Q3 | $124K | Hold |
16
| – | – | ﹤0.01% | 3782 |
|
|
2017
Q2 | $200K | Sell |
16
-1
| -6% | -$14.8K | ﹤0.01% | 3683 |
|
|
2017
Q1 | $282K | Buy |
17
+1
| +6% | +$18.1K | ﹤0.01% | 3530 |
|
|
2016
Q4 | $273K | Hold |
16
| – | – | ﹤0.01% | 3496 |
|
|
2016
Q3 | $341K | Hold |
16
| – | – | ﹤0.01% | 3403 |
|
|
2016
Q2 | $228K | Hold |
16
| – | – | ﹤0.01% | 3541 |
|
|
2016
Q1 | $255 | Hold |
16
| – | – | ﹤0.01% | 3548 |
|
|
2015
Q4 | $164K | Hold |
16
| – | – | ﹤0.01% | 3749 |
|
|
2015
Q3 | $175K | Hold |
16
| – | – | ﹤0.01% | 3727 |
|
|
2015
Q2 | $339K | Buy |
16
+1
| +7% | +$24.4K | ﹤0.01% | 3370 |
|
|
2015
Q1 | $370K | Hold |
15
| – | – | ﹤0.01% | 3320 |
|
|
2014
Q4 | $481K | Hold |
15
| – | – | ﹤0.01% | 3204 |
|
|
2014
Q3 | $455K | Buy |
15
+3
| +25% | +$84.8K | ﹤0.01% | 3211 |
|
|
2014
Q2 | $335K | Sell |
12
-2
| -14% | -$51.1K | ﹤0.01% | 3337 |
|
|
2014
Q1 | $410K | Buy |
14
+3
| +27% | +$105K | ﹤0.01% | 3234 |
|
|
2013
Q4 | $380K | Hold |
11
| – | – | ﹤0.01% | 3196 |
|
|
2013
Q3 | $252K | Buy |
11
+1
| +10% | +$32.2K | ﹤0.01% | 3225 |
|
|
2013
Q2 | $451K | Buy |
+10
| New | +$559K | ﹤0.01% | 2936 |
|
Other funds holding BIOL
AFM
ZF
TRCT
FDCDDQ
Geode Capital Management's BIOL Position: Q3 2023 in Review
Geode Capital Management sold out of Biolase, Inc. (BIOL) in Q3 2023, closing a stake of 549 shares — an estimated $3.88K sold.
Geode Capital Management first reported a position in BIOL in Q2 2013 and held it in 41 quarters. The position peaked at $1M in Q1 2021. 12 funds tracked by Wall St. Rank hold BIOL as of Q3 2023.
- Geode Capital Management reported no remaining Biolase, Inc. position as of Q3 2023 after selling out during the quarter.
- Geode Capital Management sold 549 Biolase, Inc. shares in Q3 2023, an estimated $3.88K.
- Geode Capital Management first reported a position in Biolase, Inc. in Q2 2013 and held it in 41 quarters.
- Geode Capital Management's Biolase, Inc. position peaked at $1M in Q1 2021.
- 12 funds tracked by Wall St. Rank held Biolase, Inc. as of Q3 2023.
Based on Geode Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.